commit | d13c9641a187b5a3026ebb9093aeb480fdfe1838 | [log] [tgz] |
---|---|---|
author | Richard Levasseur <rlevasseur@google.com> | Fri Jan 27 12:47:45 2023 -0800 |
committer | Copybara-Service <copybara-worker@google.com> | Fri Jan 27 12:50:33 2023 -0800 |
tree | 5f37aa640653e0c4f0882cb8910ccf003376783b | |
parent | 17e3fd1f10b31c07b5e700a457b86f119ebf1343 [diff] |
Make testLabelsOperator not depend on Python rule internals. The testLabelsOperator test was testing a case for implicit attributes by using the "$py_toolchain_type" attribute, which is only present for this test to pass. To fix, the test writes a simple Starlark rule with an implicit attribute that it queries instead of using the Python rules. PiperOrigin-RevId: 505187391 Change-Id: I8ac3f83320392f9f1a92e9f9559f41c7beaeda5a
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md